Ouazana, Marion;
Kerbage, Yohan;
Chauvet, Pauline;
Collinet, Pierre;
Bouet, Pierre;
Touboul, Cyril;
Legendre, Guillaume;
Golfier, Francois;
Ploteaus, Stephane;
Snatulli, Pietro.
To provide guidelines from the French College of Obstetricians and Gynecologists (CNGOF), based on the best currently available evidence, for the prophylactic procedures associated with gynecological surgery for benign disease such as superficial endometriosis lesions and adhesions. The CNGOF has decided...
The postnatal period, defined here as the period beginning immediately after the birth of the baby and extending
up to six weeks (42 days), is a critical time for women, newborns, partners, parents, caregivers and families. Yet,
during this period, the burden of maternal and neonatal mortality and morbid...
The Committee on Dyslipidemia of Korean Pediatric and Adolescents of the Korean Society of Pediatric Endocrinology has newly developed evidence-based clinical practice guidelines for dyslipidemia in Korean children and adolescents. These guidelines were formulated with the Grading of Recommendations, whi...
In 2013, the Society for Maternal-Fetal Medicine (SMFM)
Publications Committee adopted the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system for evaluating and rating scientific
evidence and practice recommendations for SMFM
Clinical Guidelines and Consults.1 This decision...
This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes....
This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18. The guideline recommends how to support children and young people and their families and carers to maintain tight control of blood glucose to reduce the long-term risks associated ...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications. In December 2020, we made minor changes to the ...
Diabetes Mellitus, Type 2/drug therapy,
Diabetes Mellitus, Type 2/prevention & control,
Patient Education as Topic,
Glucose/analysis,
Eye-Tracking Technology,
Dipeptidyl-Peptidase IV Inhibitors/therapeutic use,
Pioglitazone/therapeutic use,
Sulfonylurea Compounds/therapeutic use,
Platelet Aggregation Inhibitors/therapeutic use
This guideline covers managing diabetes and its complications in women who are planning pregnancy or are already pregnant. It aims to improve the diagnosis of gestational diabetes and help women with diabetes to self-manage their blood glucose levels before and during pregnancy....
This guideline covers assessment, treatment, monitoring and inpatient care for children, young
people and adults with eating disorders. It aims to improve the care people receive by detailing the
most effective treatments for anorexia nervosa, binge eating disorder and bulimia nervosa.
In December 2020, ...
This guideline covers managing acute and chronic pancreatitis in children, young people and adults.
It aims to improve quality of life by ensuring that people have the right treatment and follow-up,
and get timely information and support after diagnosis.
In December 2020, we highlighted the importance of...
